Exercise Efficacy on Autism Spectrum Disorder
Launched by ISTANBUL UNIVERSITY · Feb 14, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring whether regular exercise can help improve the health and well-being of children aged 5 to 13 who have autism spectrum disorder (ASD). The researchers want to find out if a consistent exercise program can enhance skills like movement and coordination, reduce repetitive behaviors, boost physical fitness, and improve overall quality of life. To do this, they will compare children who participate in the exercise program with those who do not to see if there are any significant benefits.
To be eligible for this trial, children must be diagnosed with autism spectrum disorder. However, children who cannot participate in the exercise program will not be included. Participants will be expected to engage in regular exercise for a period of 12 weeks. It's important to note that the trial is not currently recruiting participants, but it aims to help understand the positive effects of exercise on children with ASD.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria: children with autism spectrum disorder
- • -
- Exclusion Criteria:
- • children who are unable to adapt exercise programs
About Istanbul University
Istanbul University, a leading institution in Turkey, is dedicated to advancing healthcare through rigorous clinical research and education. Renowned for its commitment to scientific excellence and innovation, the university sponsors clinical trials that aim to enhance medical knowledge and improve patient outcomes. With a diverse team of researchers and healthcare professionals, Istanbul University fosters collaboration across disciplines to explore new therapeutic interventions and contribute to global health advancements. Its robust infrastructure and ethical standards ensure the highest quality in clinical trial management, making it a key player in the field of medical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported